A Single-Ascending-Dose Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Patients With Amyotrophic Lateral Sclerosis

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: GDC-0134;   Drug: Placebo
Sponsor:   Genentech, Inc.
Recruiting - verified November 2016
Source: 
A Single-Ascending-Dose Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Patients With Amyotrophic Lateral Sclerosis
News Type: 
Clinical Trials